Skip to content
All guides
Harm reduction

Challenging Psychedelic Experiences and How to Handle Them

What a difficult trip involves, how common it is, what helps in the moment, when it becomes a medical emergency, and where to get help if problems last.

Editorial Team6 min readUpdated

What counts as a challenging experience

A challenging experience, the term researchers now prefer to "bad trip", is a period during a psychedelic's effects when fear, confusion, grief or physical distress becomes hard to bear. Johns Hopkins researchers built a questionnaire from survey responses about difficult psilocybin experiences and found seven recurring factors: grief, fear, death, insanity, isolation, physical distress and paranoia. (Journal of Psychopharmacology, 2016) Those scores were linked both to how difficult people rated the experience and to how meaningful they later found it. (Journal of Psychopharmacology, 2016)

This article is written for the person going through it. If you are looking after someone else, the trip-sitting guide covers the sitter's side. How mindset and surroundings shape the odds of a hard trip is covered in set and setting, and what to do before a session is in how to prepare.

How common they are

The best-known numbers come from an online survey of 1,993 people describing their single most difficult experience with psilocybin mushrooms. (Journal of Psychopharmacology, 2016) Thirty-nine per cent ranked it among the five most challenging experiences of their lives. (Journal of Psychopharmacology, 2016) Eleven per cent put themselves or others at risk of physical harm, 2.6% behaved aggressively or violently and 2.7% received medical help. (Journal of Psychopharmacology, 2016) Risk rose with dose and when people lacked physical comfort and social support. (Journal of Psychopharmacology, 2016)

Read those figures carefully. Everyone in the sample was reporting their worst trip, so they describe what can happen, not how often a given trip goes badly. The same respondents were also mostly positive in hindsight: 84% said they had benefited from the experience. (Journal of Psychopharmacology, 2016) That is not a reason to seek out distress. Three cases in the survey appeared linked to the onset of lasting psychotic symptoms and three to attempted suicide. (Journal of Psychopharmacology, 2016)

Supervised research looks different. The authors note that risky behaviour and lasting distress are extremely rare when psilocybin is given to screened, prepared and supported volunteers. (Journal of Psychopharmacology, 2016) A 2024 meta-analysis of 30 controlled studies counted nine serious adverse events across more than 1,000 administrations, and retreats do not necessarily reproduce that screening and monitoring. (Psychiatry Research, 2024)

Why some trips turn hard

Difficulty is not random. In the mushroom survey, how difficult the experience was rose with the estimated dose. (Journal of Psychopharmacology, 2016) An Imperial College study that deliberately collected cases of negative responses lasting more than 72 hours interviewed 15 of the more severe cases in depth. (Scientific Reports, 2023) The factors that kept recurring were unsafe or complicated surroundings, prior psychological vulnerability, high or unknown amounts of the drug and young age. (Scientific Reports, 2023) The authors stress that a small, self-selected sample cannot show how common such outcomes are. (Scientific Reports, 2023)

That list is useful in the moment as well as beforehand. If you are in a chaotic place, getting somewhere quieter is often the single most useful step. If you do not know what or how much you took, that is information emergency staff will need.

What helps in the moment

Most difficult periods pass as the drug wears off. Research safety guidance advises against trying to fight or escape the altered state, and suggests reminding the person that they have taken a drug and that normal consciousness will return within a known time. (Journal of Psychopharmacology, 2008) Things people find useful:

  • Name what is happening. "I took a substance. This is the drug. It will end." Repeating a plain fact can cut through a spiral.
  • Breathe slowly and feel something solid. A blanket, the floor, a hand you trust. The UK drugs service FRANK suggests a quiet space, calm reassurance and slow, deep breaths for someone who is panicking or hallucinating. (FRANK (UK Government drugs advice service), current page)
  • Change one thing. Lower the lights, turn the music off or change it, move to a calmer room. Avoid bright light and loud noise. (FRANK (UK Government drugs advice service), current page)
  • Let the feeling move rather than arguing with it. Grief or fear that is allowed to run its course often eases faster than one you try to push away.
  • Do not take more of anything. Alcohol increases the chance of a bad trip, and cannabis can make it stronger, longer or less controllable. (DRUGSinfo (Drugs Infolijn), Trimbos-instituut)
  • Stay put. Do not drive or walk into traffic. Health risks are greater when psilocybin is used unsupervised, including dangerous behaviour of exactly this kind. (National Institute on Drug Abuse (NIH))

If you are alone and need a calm voice, the Fireside Project runs a free, confidential psychedelic peer support line by phone and text, open every day from 11 a.m. to 11 p.m. Pacific on 62-FIRESIDE (623-473-7433). (Fireside Project, current page) It is non-clinical support from trained volunteers, not a substitute for 911 or 988. (Fireside Project, current page)

When it is a medical emergency

Psychological distress alone is usually managed with reassurance. Some signs are different and mean you call emergency services straight away: 999 or 112 in the UK and Europe, 911 in the US. (FRANK (UK Government drugs advice service), current page; Fireside Project, current page)

Some combinations raise the stakes. Serotonin toxicity mainly arises when a drug that raises serotonin is combined with an MAO inhibitor, as in ayahuasca with SSRIs. (Psychopharmacology (Berl), 2022) In an analysis of online reports, 47% of 62 reports of lithium taken with a classic psychedelic involved seizures. (Pharmacopsychiatry, 2021) Check your own medicines with the interaction checker before, not during.

What to tell emergency staff

Tell the crew and the hospital everything you know: what was taken, roughly how much and when, whether alcohol was involved, and any medical conditions. (FRANK (UK Government drugs advice service), current page) Add every prescribed medicine, especially antidepressants, lithium and heart drugs. If any of the substance is left, hand it over so they can find out what was in it. (FRANK (UK Government drugs advice service), current page) FRANK says that in most circumstances UK medical staff will not tell the police. (FRANK (UK Government drugs advice service), current page) In the US, America's Poison Centers run a free 24-hour Poison Help line on 1-800-222-1222. (America's Poison Centers, current page)

Hospitals are loud and bright, and research guidance warns that well-meaning emergency staff who are inexperienced with hallucinogens can escalate a difficult reaction. (Journal of Psychopharmacology, 2008) That is a reason to bring a calm companion, not a reason to delay care for any of the signs above. In research settings, a benzodiazepine is the medicine of choice when reassurance is not enough. (Journal of Psychopharmacology, 2008)

What can persist afterwards

Most people are back to baseline within a day or two. A minority are not. A mixed-methods study of 608 people who reported extended difficulties found the most common were anxiety and fear, existential struggle, social disconnection, depersonalisation and derealisation. (PLOS ONE, 2023) For about a third, problems lasted more than a year, and for a sixth more than three years. (PLOS ONE, 2023) Taking the drug in a guided setting predicted a narrower range of difficulties. (PLOS ONE, 2023) The sample was recruited because they had difficulties, so it cannot say how often this happens.

People with a personal or family history of psychosis are at particular risk, and research guidelines exclude them for that reason. (Journal of Psychopharmacology, 2008; Oregon Health Authority, Public Health Division, 2026) In a survey of 541 people with bipolar disorder who had used psilocybin, 32.2% described new or worsening symptoms afterwards, prominently mania. (Journal of Psychopharmacology, 2023)

HPPD and flashbacks

Hallucinogen persisting perception disorder means visual effects similar to the drug's returning after use, in a way that is distressing or impairs functioning and is not better explained by another condition. (Journal of Psychopharmacology, 2008) Its incidence is unknown but thought to be very uncommon. (Journal of Psychopharmacology, 2008) A 2026 review notes that many people who believe they have HPPD do not meet the criteria, that brief flashbacks are more common and usually not distressing, and that in most cases HPPD fades within a year or becomes tolerable. (Current Topics in Behavioral Neurosciences, 2026) There is no evidence-based treatment yet; current practice rests on case reports and clinical experience. (Current Topics in Behavioral Neurosciences, 2026) A clinician who knows the diagnosis is worth finding rather than self-treating.

Where to get help

Making sense of the experience over the following weeks is covered in integration practices. For the wider picture on screening and risk, see Safety and the screening checklist.

Related

Questions and answers

How common are bad trips on psilocybin mushrooms?
Nobody knows the rate per trip. The largest survey asked 1,993 people about their single worst mushroom experience: 11% put themselves or others at risk of harm, 2.7% received medical help and 7.6% of those whose trip was over a year earlier sought treatment for lasting symptoms. Risk rose with dose and with no physical comfort or social support. Supervised trials with screened volunteers report far fewer serious events.Sources: Journal of Psychopharmacology, 2016; Psychiatry Research, 2024
When should I call an ambulance during a bad trip?
Call emergency services if the person is unconscious or will not wake, has trouble breathing, has blue lips or a seizure, or overheats and does not cool down. Muscle rigidity or jerking, very high temperature and wildly changing pulse or blood pressure can mean serotonin toxicity and also need immediate care. Tell the crew what was taken, when, any alcohol and all medicines.Sources: FRANK (UK Government drugs advice service), current page; Psychopharmacology (Berl), 2022
Can a bad trip cause lasting problems?
Sometimes. In a study of 608 people reporting extended difficulties, the most common were anxiety and fear, existential struggle, social disconnection and depersonalisation; for about a third they lasted over a year. Hallucinogen persisting perception disorder is rarer, and most cases fade within a year or become tolerable. A doctor can assess persistent symptoms.Sources: PLOS ONE, 2023; Current Topics in Behavioral Neurosciences, 2026Harm reduction and safety
Is there a helpline for people having a difficult psychedelic experience?
In the US, Fireside Project runs a free, confidential psychedelic peer support line by call or text on 62-FIRESIDE (623-473-7433), open 11 a.m. to 11 p.m. Pacific every day, for people during or after a trip. It is non-clinical and not a substitute for 911 or the 988 Suicide and Crisis Lifeline. In the UK, FRANK is on 0300 123 6600.Sources: Fireside Project, current page; FRANK (UK Government drugs advice service), current page

Sources

  1. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology, 2016
  2. The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. Journal of Psychopharmacology, 2016
  3. What to do in an emergency. FRANK (UK Government drugs advice service), current page
  4. Serotonin toxicity of serotonergic psychedelics. Psychopharmacology (Berl), 2022
  5. Extended difficulties following the use of psychedelic drugs: A mixed methods study. PLOS ONE, 2023
  6. Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology, 2008
  7. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology, 2016
  8. Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review. Psychiatry Research, 2024
  9. Case analysis of long-term negative psychological responses to psychedelics. Scientific Reports, 2023
  10. Paddo's: Combinatiegebruik. DRUGSinfo (Drugs Infolijn), Trimbos-instituut
  11. Psilocybin (Magic Mushrooms). National Institute on Drug Abuse (NIH)
  12. Fireside Project FAQ. Fireside Project, current page
  13. 988 Suicide and Crisis Lifeline. 988 Lifeline, current page
  14. Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports. Pharmacopsychiatry, 2021
  15. America's Poison Centers: Poison Help line. America's Poison Centers, current page
  16. Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology, 2008
  17. Client Information Form (Oregon Psilocybin Services, updated 1.1.26). Oregon Health Authority, Public Health Division, 2026
  18. Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of 'magic mushroom' consumption. Journal of Psychopharmacology, 2023
  19. Flashbacks, Hallucinogen Persisting Perception Disorder (HPPD), and Reactivations Following the Use of Classic Psychedelics: Classification and Therapeutic Management. Current Topics in Behavioral Neurosciences, 2026
  20. Coming back together: a qualitative survey study of coping and support strategies used by people to cope with extended difficulties after the use of psychedelic drugs. Frontiers in Psychology, 2024

The dispatch

Laws change. Centres change. Know before you book.

A brief, sent only in weeks when something changes: jurisdictions that shifted, listings added or revised, and the research worth reading. No hype, no sourcing talk.

Educational only. Not medical advice. Unsubscribe any time.